Sun Pharma’s Global Organon Deal Signals New Era of Indian Pharma…

Sarah J · 2026-04-29T15:48:31.000Z

Sun Pharmaceutical Industries’ $11.75 billion acquisition of US-based Organon is being viewed as a transformational moment for both the company and India Inc’s global ambitions. More than a standard acquisition, the deal represents a bold strategic move by an Indian multinational to scale globally through deliberate overseas expansion. The Economic Times:- When the world's an oyster for Sun (Pharma) - The Economic Times

Member Login Get Access

Sun Pharma’s Global Organon Deal Signals New Era of Indian Pharma… | SEINET